Grantham, Mayo, Van Otterloo & Co. LLC
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 1352662
Boston, MA
Position in VNDA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$112,785
-$111,749 QoQ
Shares Held
16,322
+24.6% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Grantham, Mayo, Van Otterloo & Co. LLC holds $93,420,610 across 9 Biotechnology names. VNDA ranks #8 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
55,353 | $42,767,941 | |
| 2 | INCY |
Incyte Corp
|
364,657 | $34,321,516 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
941,266 | $13,610,706 | |
| 4 | EXEL |
Exelixis, Inc.
|
38,235 | $1,639,899 | |
| 5 | ALT |
Altimmune, Inc.
|
126,389 | $389,278 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
11,182 | $313,207 | |
| 7 | RNA |
Atrium Therapeutics, Inc.
|
15,444 | $206,486 | |
| 8 | VNDA |
Vanda Pharmaceuticals Inc.
This page
|
16,322 | $112,785 |
All Filings in VNDA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $112,785 | 16,322 | Shares | Sole | 2026-05-14 | |
| 2021-09-30 | $224,534 | 13,100 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $191,844 | 14,600 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,326,318 | 137,300 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,905,904 | 166,600 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $207,200 | 20,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||